MC0704 is a STAT3 Inhibitor for Triple-negative Breast Cancer Research

MC0704 is a STAT3 inhibitor (IC50=2.13 μM), which can be used for the research of metastatic triple-negative breast cancer (mTNBC).

SG-094 is a Potent TPC2 Inhibitor for HCC Reasearch

Multi-targeted kinase inhibition alleviates mTOR inhibitor

Death effector domain-containing protein induces vulnerability to

MPT0E028, an Orally Active HDAC Inhibitor, Induces Apoptosis by Targeting HDAC and Akt

Navitoclax (ABT-263) is an Orally Active Bcl-2 Inhibitor for

MSAB is a Selective Inhibitor of Wnt/β-Catenin Signaling

Ficlatuzumab is a Human Hepatocyte Growth Factor (HGF) McAb

TNBC - Network of Cancer Research

PDF) Inhibition of DOT1L by Half-Selenopsammaplin A Analogs

Apitolisib is an Orally Active Class I PI3K and mTORC1/2 Inhibitor

Molecules, Free Full-Text

BAY-8002, a Monocarboxylate Transporter 1 Inhibitor for Cancer Research

MC0704 is a STAT3 Inhibitor for Triple-negative Breast Cancer